Survey measures outsourcing highs, lows; Reese gets FDA warning;

> Survey: 55 percent of biopharma organizations outsource less than half of their global manufacturing, but 18 percent use outsourcing for at least 91 percent of their output. Release

> Over-the-counter drugmaker Reese Pharmaceutical has received an FDA warning letter for manufacturing and labeling violations. Story

> Capgemini: The pharmaceutical industry needs to address patient adherence in a more strategic and integrated part of its activities. Statement

> Systech International and Videojet say they are working with a big pharma manufacturer to implement Systech's Serialized Product Tracking solution on each of its packaging lines in Brazil.  Release

> German transdermal drug developer Labtec has opened a manufacturing facility in Europe for the production of transdermal drug delivery systems and oral dispersible films using its RapidFilm technology. Story

> CMO Lonza is planning a "state-of-the-art" GMP cleanroom for its viral-based therapeutics business in Houston, Texas. Report

> Sun Pharma says it will invest $100 million to expand and upgrade Taro Pharma's facilities. Item

> Schott has opened a primary pharmaceutical packaging facility in Zavolzhe, Russia. News

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.